Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Infliximab in the treatment of ulcerative colitis with toxic megacolon
Parupudi V.J. Sriram
, K. S.Pavan Reddy
, Guduru V. Rao
, Darisetty Santosh
, Duvvuru Nageshwar Reddy
Research output
:
Contribution to journal
›
Article
›
peer-review
14
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Infliximab in the treatment of ulcerative colitis with toxic megacolon'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ulcerative Colitis
100%
Toxic Megacolon
100%
Infliximab
100%
Older Women
33%
Fatal Outcome
33%
Cyclosporine
33%
Conservative Treatment
33%
Emergency Surgery
33%
Gastrointestinal Emergencies
33%
Steroid-refractory Ulcerative Colitis
33%
Medicine and Dentistry
Ulcerative Colitis
100%
Toxic Megacolon
100%
Infliximab
100%
Fatality
33%
Conservative Treatment
33%
Cyclosporine
33%
Surgical Emergency
33%
Pharmacology, Toxicology and Pharmaceutical Science
Ulcerative Colitis
100%
Infliximab
100%
Toxic Megacolon
100%
Fatality
33%
Ciclosporin
33%